Objective-To measure the noise produced and related subjective complaints after implantation of four different mechanical heart valve prostheses and to identify further factors related to the patient and prosthesis that influence noise generation and complaints.
physically.
Setting-The measurements were conducted in silent rooms of ear, nose, and throat departments. The patients had been operated on either in a university hospital or a community hospital.
Main outcome measuresSound pressures of frequency bands and sound pressures measured in dB(A) at various distances. Complaints registerd were: sleep disturbance, disturbance during daytime, "wants a less noisy prosthesis," and "can hear the closing click".
Patients-143 patients after heart valve replacement with St Jude Medical (n = 35), Duromedics Edwards (n = 38), Carbomedics (n = 34) and Bjork-Shiley Monostrut (n = 36) prostheses operated on between 1984 and 1988 were matched for valve position, ring size, and body surface area.
Results-Duromedics Edwards (33 5 (6) dB(A)) and Bjork-Shiley Monostrut valves (31 (4) dB(A)) were significantly louder than St Jude Medical (24 (4) dB(A)) and Carbomedics (25 (6) dB(A)) prostheses (p = 010001) (mean (SD)).
The louder valves were significantly more often heard by the patients (p = 010012) and caused more complaints both during sleep (p = 0-024) and during the daytime (p = 0-07). Patients with these valves were more likely to want a less noisy valve (p = 0-0047). Patients with symptoms were younger, had better hearing, and were more likely to be in sinus rhythm. As well as the type of prostheses, the valve diameter and body height also had an effect on sound emission.
Conclusions-The intensity of the closing click of mechanical valve prostheses was significantly different for various designs. Patient complaints were related to the objectively measured sound pressure. Noise production should be considered when a mechanical valve is selected.
Replacement of stenotic or regurgitant heart valves with mechanical prostheses improves physical ability and long-term survival in patients with congenital or acquired heart valve disease. As well as the risk of complications related to the prosthesis and treatment with anticoagulants-such as embolism, bleeding, and infection-the patients can hear the closing click of the occluders that are typically made from pyrolytic carbon. Complaints about this permanent clicking are generally not noted in the clinical follow up reports. Because the rates of thromboembolic episodes (the complication most affected by valve design) are similar for the currently used mechanical valves, noise generation may well be a criterion for valve selection. We studied the sound intensity produced by various types of mechanical valve prostheses and we investigated whether there is a correlation between the sound emitted and patients' complaints related to noise. We also used octave filters to measure sound pressure levels (db SPL) for the frequencies 125, 250, and 500 Hz and 1, 2, 4, 8, and 16 kHz. All recordings were done in quiet rooms used for audiometry. The hearing threshold was determined in all patients for frequencies ranging from 125 Hz to 12 kHz for both ears. A Peters audiometer (Sheffield UK) with Telephonics TDH 39 (New York, USA) headphones was used. Patients were asked whether they could still hear the clicking after putting on the headsets. If this was the case broad spectrum noise and band noise was applied through the headsets in increasing intensity to determine the intensity of body conduction. (fig 3) . Neither systolic or diastolic blood pressure nor blood pressure amplitude correlated with the measured sound pressure for aortic and mitral prostheses.
The differences in noise generation led to significant differences in sound related complaints. Patients with noisier valves were more likely to have symptoms (table 2) and measured sound pressures were significantly louder in patients with symptoms than in those without (fig 4) . The sound pressure levels of the frequency bands were not distributed evenly within the audible range. Low and high frequencies dominated. Differences between symptomatic and symptom free patients were most significant at the higher frequencies (table  3) . The human hearing threshold attenuates low and high frequencies so that the audible noise levels between low and middle frequency ranges are equalised ( fig 5) . Patients with symptoms had better hearing. Again this difference was most significant in the high frequency ranges (table 4). As a result of higher sound pressures and better hearing the audible noise level was significantly higher for patients with symptoms ( fig 6) .
To identify factors related to the patient and prostheses that influence the noise developed we entered valve diameter, height, body weight, body surface area, body mass index, rhythm, systolic and diastolic blood pressure into a stepwise regression model. Valve diameter and body height emerged as significant variables. As the size of the prosthesis increased so did the energy released at valve closure and hence the sound pressure levels measured 1 m from the body surface correlated with the tissue annulus diameter of the implanted valve. Body height was an independent variable for developed noise. Body surface area, body weight, or body mass index as an indicator ofobesity did not influence developed sound pressure levels nor did blood pressure. Figure S Sound pressure generated by the closing click was higher in the low and high frequency ranges of the audible range, but the effective intensity was attenuated by human hearing characteristics. The high freqency bands of the closing click were perceived most intensely and symptomatic valves produced significantly more noise in these ranges than did asymptomatic ones.
consistent than in vitro results, which were obscured by the noise created by the valve tester.9 Noisy valve types clearly caused more complaints, but other variables related to the prostheses and patient also influenced noise production and the rate of complaints. Young patients had hearing in the high frequency range of the closing click (15 to 16 kHz) and thus they perceived the valve noise more intensely than older patients. Patients in sinus rhythm had more complaints than did those in atrial fibrillation, though there was no sigificant difference in measured sound pressure between regular and irregular heart beats. In the logistic regression young age was a much stronger predictor of complaints than sinus rhythm and the higher rate ofcompaints may thus have been caused by the younger age of patients in sinus rhythm.
The bigger the prosthesis and the greater the occluder mass the higher the energy release at valve closure. The sound pressure increased with annulus diameter. Blood pressure did not influence measured sound pressure nor the rate of complaints, despite its likely influence on the Figure 6 Patients who can hear their valve had louder valves and had better hearing than those who did not. As a result the difference between sound pressure and hearing was significantly greater for the asymptomatic patients (A) than for those with symptoms (B). See footnote to table 2 for abbreviations.
